HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor

被引：0
|
作者：
Vilsboll, T. [1 ]
Nicolay, C. [2 ]
Malecki, M. [3 ]
Thieu, V. Thuyanh [2 ]
Chivukula, K. [2 ]
Kiljanski, J. [2 ]
机构：
[1] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Ctr Clin Metab Res, Herlev, Denmark
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Jagiellonian Univ, Dept Metab Dis, Med Coll, Krakow, Poland
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
643
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [41] Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes
    William T. Cefalu
    Kaj Stenlöf
    Lawrence A. Leiter
    John P. H. Wilding
    Lawrence Blonde
    David Polidori
    John Xie
    Daniel Sullivan
    Keith Usiskin
    William Canovatchel
    Gary Meininger
    Diabetologia, 2015, 58 : 1183 - 1187
  • [42] The effect of frequency of meals on body weight, HbA1c and resting energy expenditure in patients with type 2 diabetes
    Kahleova, H.
    Belinova, L.
    Hill, M.
    Pelikanova, T.
    DIABETOLOGIA, 2012, 55 : S37 - S37
  • [43] Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes
    Cefalu, William T.
    Stenlof, Kaj
    Leiter, Lawrence A.
    Wilding, John P. H.
    Blonde, Lawrence
    Polidori, David
    Xie, John
    Sullivan, Daniel
    Usiskin, Keith
    Canovatchel, William
    Meininger, Gary
    DIABETOLOGIA, 2015, 58 (06) : 1183 - 1187
  • [44] Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS
    Peters, Anne L.
    Buzzetti, Raffaella
    Lee, Clare J.
    Pavo, Imre
    Liu, Minzhi
    Karanikas, Chrisanthi A.
    Paik, Jim S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 110 (04): : e962 - e969
  • [45] Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide
    Paul, S.
    Best, J.
    Klein, K.
    Han, J.
    Maggs, D.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 826 - 834
  • [46] The effect of weight loss on HbA1c levels
    Jecht, M.
    DIABETOLOGE, 2017, 13 (07): : 519 - 521
  • [47] Sustainability of HbA1c control of tirzepatide vs insulin glargine in people with type 2 diabetes and increased cardiovascular risk: SURPASS-4
    Kahn, S. E.
    Del Prato, S.
    Pavo, I.
    Franco, D. R.
    Yang, Z.
    Wiese, R. J.
    Pearson, E. R.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S284 - S284
  • [48] HbA1c in an unselected population of 4438 people with Type 2 diabetes in a Danish county
    Kristensen, JK
    Bro, F
    Sandbæk, A
    Dahler-Eriksen, K
    Lassen, JF
    Lauritzen, T
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2001, 19 (04) : 241 - 246
  • [49] Seasonal variation in visceral fat and blood HbA1c in people with type 2 diabetes
    Iwata, Kazuko
    Iwasa, Motoh
    Nakatani, Tomoe
    Yano, Yutaka
    Mifuji-Moroka, Rumi
    Hara, Nagisa
    Akamatsu, Miho
    Ishidome, Masumi
    Takei, Yoshiyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (03) : E53 - E54
  • [50] POSITIVE AFFECT PROSPECTIVELY PREDICTS HBA1C AMONG PEOPLE WITH TYPE 2 DIABETES
    Horner, Fiona
    Helgeson, Vicki S.
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S323 - S323
12345